Article Details

Lynparza approved in Japan as adjuvant treatment for patients with BRCA-mutated ... - Cision News

Retrieved on: 2022-08-25 06:03:01

Tags for this article:

Click the tags to see associated articles and topics

Lynparza approved in Japan as adjuvant treatment for patients with BRCA-mutated ... - Cision News. View article details on HISWAI: https://news.cision.com/se/astrazeneca/r/lynparza-approved-in-japan-as-adjuvant-treatment-for-patients-with-brca-mutated-her2-negative-high-r,c3619975

Excerpt

First and only approved medicine targeting BRCA mutations in early breast cancer. AstraZeneca and.

Article found on: news.cision.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up